陈菲,潘晨,王瑞睿,姚怡然,王岚,刘琦,杨杰
CHEN Fei,PAN Chen,WANG Ruirui,YAO Yiran,WANG Lan,LIU Qi,YANG Jie

• 1:贵州医科大学附院消化内科

摘要(Abstract)：

目的:探索阿莫西林联合克拉霉素、四环素联合呋喃唑酮、氧氟沙星联合庆大霉素4种抗生素组合对根除幽门螺杆菌(H.Pylori)的疗效及安全性。方法:选择C14呼气试验阳性的H.pylori感染、并伴有消化不良症状患者210例,采用分段随机法分为3组,A组使用阿莫西林联合克拉霉素治疗,B组使用四环素联合呋喃唑酮治疗,C组使用氧氟沙星联合庆大霉素治疗,各组均加入兰索拉唑及胶体果胶铋,疗程14 d;治疗结束4周后复查C14呼气试验,阴性者为H.pylori根除成功;记录并比较3组患者H.pylori行意向性(ITT)及符合方案(PP)根除率、症状缓解率,不良反应ITT及PP发生率。结果:与A、C两组治疗方案比较,B组ITT和PP根除率最高(P<0.05);3种治疗方案的症状缓解率均高于80%,各种治疗方案比较,差异无统计学意义(P>0.05);不良反应发生率B组最高,但3组间比较,差异无统计学意义(P>0.05),且所有不良反应均于停药后消失。结论:3种四联方案治疗H.Pylori感染并消化不良症的安全性较好,其中四环素联合呋喃唑酮方案H.pylori根除率最高。
Objective: To explore the curative effect and safety of 3 combinations of antibiotics(amoxicillin combined with clarithromycin,tetracycline combined with furazolidone,ofloxacin combined with gentamicin) in the eradication of Helicobacter pylori(H. pylori). Method: 210 cases of patients with H. pylori infection in positive C14 breath test and digestive symptoms were selected and divided into 3 groups by piecewise stochastic method. Group A adopted amoxicillin combined with clarithromycin treatment,group B tetracycline combined with furazolidone treatment,and group C ofloxacin combined with gentamicin treatment. The lansoprazole and colloidal bismmth pectin were added into the three groups. The process of treatment lasted 14 d. 4 weeks after treatment,C14 breath test was adopted again to reexamine. Negative meant successful eradication of H. pylori. The intention to treat(ITT) and per-protocol(PP) eradication rate,symptom remission rate and the incidence of adverse reaction ITT and PP in three groups have been recorded and compared,respectively. Results: Compared with group A and group C,in group B the ITT and PP eradication rate was the highest(P < 0. 05);The symptom remission rates in 3 groups were all more than 80%,and there was no statistically significant difference between the three groups(P > 0. 05). The incidence rate of adverse reaction in group B was the highest,but there was no statistically significant difference between the 3 groups. All adverse reactions disappeared after drug withdrawal. Conclusions: The safety of three combinations of 4 antibiotics in the treatment of H. pylori infection and dyspepsia is relatively good,of which the eradicationrate of H. pylori by tetracycline combined with furazolidone is the highest.

关键词(KeyWords)： 四环素;幽门螺杆菌;四联疗法;耐药率;根除率
tetracycline;Helicobactor pylori;quadruple therapy;drug resistance rate;eradication rate

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 陈菲,潘晨,王瑞睿,姚怡然,王岚,刘琦,杨杰
CHEN Fei,PAN Chen,WANG Ruirui,YAO Yiran,WANG Lan,LIU Qi,YANG Jie

参考文献(References)：

• [1]Malfertheiner P,Megraud F,O'Morain CA,et al.Management of helicobacter pylori infection--the maastricht IV/florence consensus report[J].Gut,2012(5):646-64.
• [2]第四次全国幽门螺杆菌感染处理共识报告[J].内科理论与实践,2013(1):54-60.
• [3]刘正美,周建奖,赵艳,等.幽门螺杆菌临床菌株的分离培养和鉴定[J].贵阳医学院学报,2016(4):402-406.
• [4]王琼,杨杰,潘科,等.幽门螺杆菌不同运送条件及培养基分离效果的比较[J].世界华人消化杂志,2016(8):1241-1246.
• [5]韩丰,冀子中,金夏,等.2009年-2013年浙江嘉兴地区幽门螺杆菌对常用抗菌药物的耐药研究[J].胃肠病学,2016(6):353-357.
• [6]孟霞,刘改芳,吴婧,等.河北地区幽门螺杆菌临床分离株的耐药性分析[J].中华医学杂志,2016(4):270-272.
• [7]杨麒臻,周力,刘苓.含阿莫西林和铋剂的四联方案根除幽门螺杆菌的疗效观察[J].贵阳医学院学报,2015(10):1073-1076.
• [8]杨杰,吕锐,李丽滨,等.铋剂四联方案根除幽门螺杆菌的比较研究[J].临床消化病杂志,2010(5):277-278,281.
• [9]张维,陆红.含铋剂的根除幽门螺杆菌方案在我国应用的经验与建议[J].中华消化杂志,2014(9):646-648.
• [10]冷佳源,袁桂林,唐茜,等.重庆地区2014年幽门螺杆菌临床分离株耐药性分析[J].中国药房,2016(11):1487-1490.
• [11]张万岱,胡伏莲,胡品津,等.幽门螺杆菌共识意见(2003·安徽桐城)[J].中华消化杂志,2004(2):62-63.
• [12]幽门螺杆菌胃炎京都全球共识研讨会纪要[J].中华消化杂志,2016(1):53-57.
• [13]刘苓,胡林,刘娅琳,等.贵州省幽门螺杆菌临床菌株的抗生素耐药现状[J].胃肠病学和肝病学杂志,2012(8):702-705.

文章评论(Comment)：